A natural, non-invasive and permanent treatment to regenerate blood vessels and smooth muscles within the sexual organ of patients with erectile dysfunction. A real 'bombshell' to revive their sex life. It's called CaverStem * and is a patented medical protocol in the United States, also available in Italy. 60 patients have already been treated in a few months after the go-ahead by the Ministry of Health to the device. This new therapy is added to platelet-rich plasma (Prp) which has already given widely documented positive effects in the treatment of erectile dysfunction and penile pathological curvatures caused by La Peyronie's disease.
Now the hematopoietic, mesenchymal and endothelial progenitor cells present in the patient's bone marrow take on a leading role in the treatment of erectile dysfunction. Erectile dysfunction is a condition closely related to age, psychological, neurological and hormonal factors. It has an extremely significant impact on the quality of life of the patient and therefore reflected in the social fabric. Epidemiological data in Italy place the problem, in terms of prevalence, among those most frequently encountered. Currently around 3 million men are affected by erectile dysfunction, but it is estimated that they could be at least twice as many. In the field of biomedical research, regenerative medicine has successfully established itself over the last decade through the development of new strategies and alternative treatments to conventional therapies, using growth factors and other intercellular signals capable of stimulating the natural healing process of the human body. The hematopoietic, mesenchymal and endothelial progenitor cells used in the patient's bone marrow are used. The administration of stem cells directly into the penis can reverse the pathophysiological changes that lead to erectile dysfunction, in addition to treating the symptoms effectively. In about 15 minutes, a small amount of autologous material from the iliac crest is extracted from the patient, and obtains a concentrated cellular product which is injected into the corpus cavernosum of the penis of the patient himself. The CaverStem * procedure, scientifically already validated in the USA, allows a safe, fast and free of side effects sampling to be performed on an outpatient basis. In Rome the only authorized European center for this treatment.
Just three months after implantation, an increase in the duration and frequency of the erection was detected, in addition to maintaining it until reaching orgasm.
Side effects are virtually absent and no post-procedure complication has occurred. Some patients have even been treated with a double stem cell and Prp graft, with truly exceptional results in terms of resumption of sexual activity that allow us to glimpse a truly rosy future for the non-invasive and non-surgical treatment of erectile dysfunction.
AI
